Sector ratings Legend Biotech Corporation
Equities
LEGN
US52490G1022
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
39.59 USD | +0.38% |
|
+10.37% | +21.67% |
07-09 | US lawmakers renew concerns about GenScript's ties to China | RE |
07-07 | RBC Lowers Price Target on Legend Biotech to $75 From $78, Keeps Outperform Rating | MT |
Main competitors
Fundamentals (Composite) | Global Valuation (Composite) | Consensus (Composite) | Financial estimates revisions (Composite) | Visibility (Composite) | Investor (Composite) | ESG MSCI | Capi.($) | ||
---|---|---|---|---|---|---|---|---|---|
- | - | - | B | 7.27B | |||||
AA | 34.85B | ||||||||
AAA | 31.35B | ||||||||
AAA | 13.87B | ||||||||
B | 13.52B | ||||||||
AA | 13.21B | ||||||||
BB | 12.43B | ||||||||
- | - | 6.21B | |||||||
A | 5.95B | ||||||||
BB | 5.88B | ||||||||
Average | A | 14.45B | |||||||
Weighted average by Cap. | A |
- Stock Market
- Equities
- LEGN Stock
- Sector Legend Biotech Corporation
- Sector ratings
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition